CEREBROLYSIN 60mg

Cerebrolysin 60 mg — Peptide-Based Neurotrophic Complex for CNS Research

Cerebrolysin is a peptide-based neurotrophic complex composed of
low–molecular weight peptides and amino acids derived from enzymatic protein hydrolysates.
In preclinical and clinical research, Cerebrolysin has been investigated for its potential
effects on neuronal survival, synaptic plasticity, cognitive performance, and
recovery after CNS injury.

What It Is

• Class: Peptide and amino-acid neurotrophic mixture
• Composition: Low–molecular weight peptides & free amino acids
  (exact profile may vary by lot/specification)
• Research focus: Neuroprotection, neuroplasticity, cognition, and
  recovery in central-nervous-system models.

Metabolic & Anti-Inflammatory Pathways

• Used in models assessing oxidative stress, mitochondrial function,
  and apoptotic signaling in neurons.
• Preclinical work includes effects on neuroinflammatory markers
  and glial-cell responses after injury.
• Interest in combined neuroprotective and neurorestorative
  profiles in chronic CNS conditions.

Selected Research Highlights

• Stroke & Ischemia Models: Cerebrolysin has been studied in
  ischemic brain injury for impacts on infarct size, functional recovery,
  and neurologic scores in animal and clinical research.
• Cognitive & Memory Research: Experimental work examines
  learning, memory, and executive-function endpoints in aging and
  disease-related models.
• Neurodegenerative Contexts: Investigated in preclinical and selected
  clinical settings for effects on cognitive decline and neurodegenerative
  markers.